Valuation: Ainos, Inc.

Market Cap 13.48M 11.82M 10.91M 10.08M 19.11M 1.29B 19.5M 131M 50.98M 632M 50.61M 49.5M 2.19B P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 24.06M 21.1M 19.48M 18M 34.12M 2.3B 34.81M 234M 91M 1.13B 90.35M 88.37M 3.91B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
33.62%
Yield 2024 *
-
Yield 2025 -
1 day+1.64%
1 week-0.53%
Current month-4.12%
1 month-8.82%
3 months+10.06%
Current year+13.41%
1 week 1.81
Extreme 1.8136
2.08
1 month 1.72
Extreme 1.72
2.31
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.5
3 years 1.26
Extreme 1.26
30.5
5 years 1.26
Extreme 1.26
450
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 72 15/04/2021
Director/Board Member 68 15/06/2022
Director/Board Member 49 15/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-05Buy

Director

3,500 0.0501%
06-03Buy

Director

2,000 0.0286%
05-28Buy

Director

250 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%-0.53%-41.69%-89.37% 13.48M
+1.88%-0.90%+23.54%+0.37% 190B
-0.52%-2.89%-21.67%+21.58% 147B
+1.70%-2.03%-3.51%-17.30% 135B
+0.36%-0.38%-56.32%-14.67% 66.6B
-1.61%-2.30%+19.45%+0.61% 53.92B
+0.53%-1.34%-27.24%-30.62% 43.57B
+1.70%+0.20%+7.96%+10.64% 36.45B
+2.27%-0.88%+7.66%+42.05% 36.15B
+0.59%-1.07%-18.98%-4.26% 29.69B
Average +0.86%+0.06%-11.08%-8.10% 73.8B
Weighted average by Cap. +0.86%+1.62%-4.18%+0.55%

Financials

2024 2025
Net sales 20.73K 18.18K 16.79K 15.51K 29.4K 1.98M 29.99K 202K 78.41K 971K 77.84K 76.14K 3.37M 124K 109K 101K 92.91K 176K 11.89M 180K 1.21M 470K 5.82M 466K 456K 20.2M
Net income -14.86M -13.04M -12.04M -11.12M -21.08M -1.42B -21.5M -145M -56.22M -696M -55.82M -54.59M -2.42B -14.77M -12.96M -11.96M -11.05M -20.95M -1.41B -21.37M -144M -55.87M -692M -55.47M -54.25M -2.4B
Net Debt 8.11M 7.11M 6.56M 6.07M 11.5M 776M 11.73M 78.92M 30.66M 380M 30.44M 29.78M 1.32B 10.58M 9.28M 8.57M 7.92M 15.01M 1.01B 15.31M 103M 40.03M 496M 39.74M 38.87M 1.72B
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
09/07/26 US$1.860 +1.64% 53,660
08/07/26 US$1.830 -2.66% 23,966
07/07/26 US$1.880 -7.84% 68,040
06/07/26 US$2.040 +9.09% 33,131
02/07/26 US$1.870 -8.33% 54,787
  1. Stock Market
  2. Stocks
  3. AIMD Stock